
伟杰信生物
伟杰信生物
Biotech/Healthcare
Beijing Weijiexin Biotechnology focuses on reproductive hormone drug R&D, developing hormone therapies for both veterinary and human use. Its business covers recombinant drugs for human reproduction, recombinant drugs for animal reproduction, and reproductive health technical services and clinical…
Latest round: Series C (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-05-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.